top of page
AI pixabay huge.jpg

Digital Biomarkers – An Industry Game Changer

Digital biomarkers refer to the quantifiable, physiological, and behavioural data collected and measured by means of digital devices. These devices include sensors, wearables, implantables, and mobile phones. Digital biomarkers offer a patient-centric approach to therapeutics with the attitude that no one device is applicable to all cases. In particular, sensor technology is selected on a case-to-case basis during a data analytics phase where the goal is to extract objective measures reflecting a typical disease manifestation. This information is used to align with targeted concepts of interest and enhance the value of medicine through objective or real-world patient data.

Developing Digital Biomarkers for Rheumatoid Arthritis: a GSK Case Study

While there are some broad cross therapy applications, each disease area has its own unique set of challenges and requirements, resulting in a diversity of applications across the GSK portfolio. The digital biomarkers team at GSK focuses on assessing efficacy, safety, and patient stratification. In his presentation, Valentin Hamy, Data Analytics Leader – Digital Biomarker at GSK focused on efficacy with a case study on rheumatoid arthritis where GSK aim to capture patient function for the generation of patient-centric endpoints.


bottom of page